<DOC>
	<DOCNO>NCT01619618</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This laboratory study look biomarkers sample patient recurrent metastatic head neck cancer treat ECOG-E1302 trial .</brief_summary>
	<brief_title>Studying Biomarkers Samples From Patients With Recurrent Metastatic Head Neck Cancer Treated ECOG-E1302 Trial</brief_title>
	<detailed_description>OBJECTIVES : - To evaluate frequency ATP-binding cassette , sub-family G ( WHITE ) , member 2 ( ABCG2 ) , meet proto-oncogene ( hepatocyte growth factor receptor ) ( c-MET ) , v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( K-ras ) polymorphisms mutation study population predictiveness polymorphism survival , time progression , response rate , toxicity . OUTLINE : Archived tumor tissue peripheral blood mononuclear cell analyzed frequency ABCG2 , c-MET , K-ras polymorphism mutation polymerase chain reaction ( PCR ) . Results correlate patient ' clinical outcome toxicity .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients diagnose recurrent metastatic head neck cancer treat Eastern Cooperative Oncology Group ( ECOG ) E1302 trial Patients treat docetaxel versus without gefitinib Existing paraffin block peripheral blood mononuclear cell PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IVA squamous cell carcinoma larynx</keyword>
	<keyword>stage IVB squamous cell carcinoma larynx</keyword>
	<keyword>stage IVC squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVB squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVC squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage IVA salivary gland cancer</keyword>
	<keyword>stage IVB salivary gland cancer</keyword>
	<keyword>stage IVC salivary gland cancer</keyword>
</DOC>